IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Pharma Investment Ltd

CUSIP: 44052TAA9 | 6 institutional holders

Quarters

Q3 2018Q2 2018Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

Russell Investments Group, Ltd.488,000
0.0% of portfolio›$491
StyleTurnoverLocationFiled
Russell Investments Group, Ltd.
488,000$4910.0%CoreLowSeattle, WA2018-10-26